Font Size: a A A

Clinical Observation Of The Prescription Of Benefiting Qi And Activating Blood Circulation On Chronic Atrophic Gastritis

Posted on:2020-10-18Degree:MasterType:Thesis
Country:ChinaCandidate:J Y XuFull Text:PDF
GTID:2404330572476186Subject:Traditional Chinese Medicine
Abstract/Summary:PDF Full Text Request
Objective:The aim of this dissertation is to discuss the clinical efficacy of the tutor's prescription of benefiting qi and activating blood circulation in the treatment of Chronic Atrophic Gastritis.We observe the impact of the prescription of benefiting qi and activating blood circulation on spleen-stomach deficiency,TCM syndrome of gastric stasis of Chronic Atrophic Gastritis,gastroscope,pathological improvement and levels of PG and ET.This helps to explain the mechanism of the prescription of benefiting qi and activating blood circulation in the treatment of Chronic Atrophic Gastritis in combination with modern medicine,and prevent the further development of Atrophic Gastritis and even the possibility of becoming cancer.These provide a theoretical basis for the clinical efficacy of the prescription of benefiting qi and activating blood circulation.Methods:66 cases of Western medicine diagnosed as Chronic Atrophic Gastritis and TCM syndrome differentiation belonged to spleen-stomach deficiency and gastric stasis were clinically selected,which were divided into two groups,33 cases in each group,according to random number method.The treatment group was treated with the prescription of benefiting qi and activating blood circulation and the control group used Weifuchun tablets for three months as a course of treatment.After a course of treatment,the TCM syndrome efficacy,gastroscopy,pathological tissue examination,PG and ET were compared before and after treatment.Results:(1)In the overall clinical efficacy evaluation,the total effective rate of the treatment group was 68.8%,and the total effective rate of the control group was 43.3%.The difference of the treatment between the two groups was statistically significant(P<0.05).It showed that the treatment group improved the overall clinical efficacy better than the control group.(2)In the evaluation of TCM clinical syndrome scores,the difference in TCM clinical syndrome scores between the two groups before and after treatment was statistically significant(P<0·01).After the treatment in the two groups,the difference in TCM clinical syndrome scores between the groups was statistically significant(P<0.01).It showed that the treatment group has better TCM clinical syndrome scores than the control group.(3)In the evaluation of gastroscope integral,the difference of gastroscopic scores before and after treatment in the treatment group was statistically significant(P<0.01).The difference of gastroscopic scores before and after treatment in the control group was statistically significant(P<0.05).After the treatment in the two groups,the difference in gastroscopic scores between the groups was statistically significant(P<0.01).It showed that the treatment group reduced the gastroscope integral effect significantly better than the control group.In the pathological score evaluation,the difference in pathological scores before and after treatment in the treatment group was statistically significant(P<0.01).The difference of pathological scores before and after treatment in the control group was statistically significant(P<0.05).After the treatment in the two groups,the difference in pathological scores between the groups was statistically significant(P<0.05).It showed that the treatment group reduced the pathological score significantly better than the control group.And the difference in gastric mucosal atrophy between the two groups after treatment was statistically significant(P<0.05).The difference in intestin al metaplasia was not statistically significant(P>0.05).The difference in dysplasia was not statistically significant(P>0.05).It showed that the treatment group has better improvement of gastric mucosal atrophy.(4)In the PGI and PG?/? evaluations,the difference between the two groups before and after treatment was not statistically significant(P>0.05),so it was not considered that the two treatment methods has an impact on the intervention of PGI and PGI/II.(5)In the ET evaluation,the difference in ET between the two groups was statistically significant(P<0.01).After the.treatment in the two groups,the difference between the groups was statistically significant(P<0.01).It showed that the treatment group improved ET effect significantly better than the control group.Conclusion:The prescription of benefiting qi and activating blood circulation has significant clinical efficacy on spleen-stomach deficiency and gastric stasis of Chronic Atrophic Gastritis.The prescription of benefiting qi and activating blood circulation also has significant improvement on clinical symptoms,gastric mucosa,histopathology and ET.It has high clinical significance and research value.
Keywords/Search Tags:The prescription of benefiting qi and activating blood circulation, Chronic Atrophic Gastritis, Clinical research
PDF Full Text Request
Related items